Himes and hers health Donate $1 million to the president-elect Donald Trump”Q Opening boxCNBC confirmed on Tuesday.
The company, which offers a range of direct-to-consumer treatments for conditions such as weight loss, erectile dysfunction and hair loss, is the latest in a string of technology companies that have tried to curry favor with the incoming administration. OpenAI CEO Sam Altman dead Both declared $1 million donations To the inaugural fund late last year, and Amazon and apple CEO Tim Cook also reportedly contributed.
“At Hims & Hers, we stand with leaders and advocates committed to improving America's broken health care system,” the company said in a statement to CNBC.
Axios The Hims & Hers donation was first reported.
Himes and Herz was a Breakout star in the digital health sector last year, thanks in large part to the success of its popular new weight loss offering.
The company began to describe Semaglutide compound Through its platform in May after launching a weight loss program in late 2023. Semaglutide is the active ingredient in Novo NordiskPopular medications Ozempic and Wegovy, which can cost about $1,000 a month without insurance. Semaglutide is a cheaper, tailored alternative to brand-name drugs and can be produced when brand-name treatments are in use. loss.
The future of combination GLP-1 drugs in the United States is not entirely clear, especially since members of Trump's circle have expressed conflicting opinions about the drugs more broadly. Robert F. kennedy jrTrump's pick to lead the Department of Health and Human Services, criticized the GLP-1s. He said CNBC in an interview The “first line of response” to obesity should be lifestyle changes, although he added that “GLP medications have a place.”
Dr. Marty McCurry, Trump's pick to lead the FDA, served as CEO of the telehealth company Sesame, which connects consumers with doctors who can prescribe compounded GLP-1s. However, McCarey's role on Sesame has been mostly ceremonial in recent years.
Elon Muskthe Tesla The CEO, who has been a Trump confidant since the election, has publicly expressed his support for the drugs.
“Nothing could do more to improve the health, longevity, and quality of life of Americans than making GLP inhibitors extremely low-cost to the public,” Musk wrote in his article. job on his social media platform X in December.
At an event with reporters in New York City late last year, which CNBC attended, Hims & Hers said it would work with the incoming administration and share the company's view on the value of drugs.
